New data point to greater deaths in patients receiving Medtronic Inc's AneuRx stent graft system, which treats artery bulges in the abdomen, the U.S. Food and Drug Administration said on Tuesday.
About 1.2 million Americans have such a bulge, according to Medtronic, but only 15 percent are diagnosed and half are never treated.
and:
A common new technology for monitoring defibrillators is vulnerable to hacking and even to reprogramming that could stop the devices from delivering a lifesaving shock, according to research to be released Wednesday.
In the model researchers studied, transmissions from the defibrillator to the bedside monitor are not encrypted, which means that someone intercepting the transmissions could retrieve such data as the patient's birth date, medical ID number and, in some cases, Social Security number.
No comments:
Post a Comment